Advertisement

The epithelial changes associated with Helicobacter pylori infection: the biology of gastric and intestinal metaplasia

  • N. Wright

Abstract

It is now abundantly clear that Helicobacter pylori has an aetiological role in the pathogenesis of chronic gastritis and peptic ulcer in both the stomach and the duodenum1,2, and highly likely that it is incriminated in the induction of carcinoma of the stomach3 and low-grade gastric (MALT) lymphoma4. However, the actual mechanisms by which this organism exerts its effects have not yet been elucidated. What is clear is that colonization and adhesion of the bacteria to the mucosal surface, followed either by the production of toxin(s) and/or mucosal invasion, are the prerequisites for induction of tissue damage. This implies that adhesion of the organism to the epithelial cells of the gastroduodenal mucosa is an extremely important step. The organism maintains a microenvironment with a more neutral pH immediately adjacent to the mucosa5, with direct adhesion of the organism to the apical plasma membrane of the epithelial cell to form the characteristic adhesion pedestal6, with some authors suggesting a preference for intercellular junctions7.

Keywords

Duodenal Ulcer Pylorus Infection Intestinal Metaplasia Clinical Cure Paneth Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Henschel E, Bradstatter G, Dragosics B et al. Effect of ranitidine and amoxycillin plus metranidazole on the eradication of H. pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993;328:308–12.CrossRefGoogle Scholar
  2. 2.
    Moss SJ. Helicobacter pylori and peptic ulcers: the current position. Gut. 1992;33:289–92.PubMedCrossRefGoogle Scholar
  3. 3.
    Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 1993;341:1359–62.CrossRefGoogle Scholar
  4. 4.
    Wotherspoon AC, Ortiz-Haldago C, Falzon MR et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Marshall BJ, Barrett LJ, Prakash C et al. Urea protects Helicobacter pylori from the bactericidal effects of acid. Gastroenterology. 1990;99:697–702.PubMedGoogle Scholar
  6. 6.
    Dytoc M, Gold B, Louie M et al. Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect Immun. 1993;61:448–56.PubMedGoogle Scholar
  7. 7.
    Kazi JL, Sinniah R, Zaman V et al. Ultrastructural study of Helicobacter pylori-associated gastritis. J Pathol. 1990;16:65–70.CrossRefGoogle Scholar
  8. 8.
    Wyatt JI, Rathbone BJ, Sobola GM et al. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol. 1990;43:981–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Sherman PM. Adherence and internalisation of H. pylori by epithelial cells. In: Hunt R, Tytgat G, editors. Helicobacter pylori; basic mechanisms to clinical cure. London: Kluwer; 1994:148–62.Google Scholar
  10. 10.
    Gregory MA, Spitaels JM. Variation in the morphology of villus epithelial cells within 8 mm of untreated duodenal ulcers. J Pathol. 1987; 153:109–19.PubMedCrossRefGoogle Scholar
  11. 11.
    Lui KC, Wright NA. The migration pathway of epithelial cells on human duodenal villi: the origin and fate of ‘gastric metaplastic’ cells on duodenal villi. Epith Cell Biol. 1992;1:53–8.Google Scholar
  12. 12.
    Hanby AW, Poulsom R, Elia G et al. The expression of the trefoil peptides pS2 and human spasmolytic Polypeptide (hSP) in gastric metaplasia of the proximal duodenum; implications for the nature of gastric metaplasia. J. 1993;169:355–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Khulusi S, Hanby AM, Marrers JM et al. Expression of trefoil peptides pS2 and human spasmolytic Polypeptide in gastric metaplasia at the margins of duodenal ulcers. Gut. 1995;37:205–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Kuhl P, Naczaco K, Malfertheimer P. How does gastric metaplasia in the duodenum differ from gastric epithelium? Gut. 1995;37(Suppl.):A29.Google Scholar
  15. 15.
    Robert IS, Stoddart RW. The ulcer-associated cell lineage in Crohn’s disease: a lectin histochemical study. J Pathol. 1993;171:13–19.CrossRefGoogle Scholar
  16. 16.
    Wright N, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in gastrointestinal stem cells. Nature. 1990;343:82–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Ahnen D, Poulsom R, Stamp GWH et al. The ulceration-associated cell lineage (UACL) reiterates the Brunner’s gland differentiation programme but acquires the proliferative organisation of the gastric gland. J Pathol. 1994;173:317–26.PubMedCrossRefGoogle Scholar
  18. 18.
    Ahnen D, Gullick W, Wright NA. Expression of multiple growth factors by the ulcer-associated cell lineage in Crohn’s disease. Gastroenterology. 1991;100:A512.Google Scholar
  19. 19.
    Levi S, Beardshall K, Haddad G et al. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989;1:1167–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Heitz P, Kasper M, Van Noorden S et al. Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands. Gut. 1978;19:408–13.PubMedCrossRefGoogle Scholar
  21. 21.
    Playford RJM, Marshbank T, Chinery R et al. Human spasmolytic Polypeptide is a cytoprotective agent which stimulates cell migration. Gastroenterology. 1995;108:108–16.PubMedCrossRefGoogle Scholar
  22. 22.
    Steer HW. Ultrastructure of cell migration through the gastric epithelium and its relationship to bacteria. J Clin Pathol. 1975;28:639–45.PubMedCrossRefGoogle Scholar
  23. 23.
    Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol. 1991;6:125–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Carrick J, Lee A, Hazell D et al. Campylobacter pylori, duodenal ulcer and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut. 1989;30:790–07.PubMedCrossRefGoogle Scholar
  25. 25.
    Harris AW, Walker HM, Smotka A et al. Parietal cells in the duodenal bulb: the relation to Helicobacter pylori infection. J Clin Pathol. 1996;40:309–12.CrossRefGoogle Scholar
  26. 26.
    Walker MM, Dixon MF. Gastric metaplasia: its role in duodenal ulceration. Aliment Pharmacol Ther. 1996;10(Suppl. 1): 119–28.PubMedGoogle Scholar
  27. 27.
    Wyatt JL, Rathbone BJ, Sobola GM et al. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol. 1990;43:981–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Fitzgibbons PL, Dooley CP, Cohen H et al. Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum in members of a normal population. Am J Clin Pathol. 1988;90:711–14.PubMedGoogle Scholar
  29. 29.
    Rhodes J. Experimental production of gastric epithelium in the duodenum. Gut. 1964;5:454–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Tatsuta M, Ishii H, Yamamura H et al. Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut. 1989;30:311–15.PubMedCrossRefGoogle Scholar
  31. 31.
    Kruning J, van der Wal JM, Kuiper G et al. Chronic non-specific duodenitis: a multiple biopsy study of the duodenal bulb in health and disease. Scand J Gastroenterol. 1989;24(Suppl. 167): 16–20.CrossRefGoogle Scholar
  32. 32.
    Harris AW, Gummen PA, Waller JM et al. The relationship between gastric acid output and gastric metaplasia of the duodenal bulb. Gut. 1994;34(Suppl. 5):S49.Google Scholar
  33. 33.
    Shahib SM, Cutz E, Drumm B et al. Association of gastric metaplasia and duodenitis with Helicobacter pylori infection in children. Am J Clin Pathol. 1994; 102:188–91.Google Scholar
  34. 34.
    Marshall BJ, McCechie DB, Rogers PA et al. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985;142:439–44.PubMedGoogle Scholar
  35. 35.
    Yang HT, Dixon MF, Zuo JS et al. Helicobacter pylori infection and gastric metaplasia in China. J Clin Gastroenterol. 1995;20:100–12.CrossRefGoogle Scholar
  36. 36.
    Wyatt JL, Rathbone BJ, Dixon MF et al. Campylobacter pyloridis and acid-induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol. 1987;40:841–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Dixon MF, Sobala GM, Wyatt JL et al. Gastric metaplasia and H. pylori associated gastritis as predictors of the duodenal ulcer diathesis. Irish J Med Sci. 1992; 161 (Suppl. 10): 11.Google Scholar
  38. 38.
    Fullman W, Van Deventer G, Schneidmann D et al. Healed duodenal ulcers are histologically ill. Gastroenterology. 1985;88:1390.Google Scholar
  39. 39.
    Moshal MC, Gregiry MA, Pillay D et al. Does the duodenal cell ever return to normal? A comparison between treatment with Cemitidine and Denol. Scand J Gastroenterol. 1979; 14(Suppl. 54): 48–51.Google Scholar
  40. 40.
    Noach LA, Rolf TM, Bosma NB et al. Acid and gastric metaplasia in the duodenum. Gut. 1995;36(Suppl. 1):A51.CrossRefGoogle Scholar
  41. 41.
    Khulusi S, Patel P, Badve S et al. Pathogenesis of gastric metaplasia in duodenal ulcer disease. Gut. 1995;36(Suppl. 1):A51.Google Scholar
  42. 42.
    Khulusi S, Mendall MA, Badve S et al. Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut. 1995;36:193–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Harris AW, Walker MM, Waller JM et al. Gastric metaplasia in the duodenal bulb before and six months after eradication of Helicobacter pylori. Gastroenterology. 1995; 108: A108.CrossRefGoogle Scholar
  44. 44.
    Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer. 1955;9;377–85.PubMedCrossRefGoogle Scholar
  45. 45.
    Stemmermann GN. Intestinal metaplasia of the stomach: a status report. Cancer. 1994;74:356–62.CrossRefGoogle Scholar
  46. 46.
    Matsukara M, Suzuki K, Kawachi et al. Distribution of marker enzymes and mucin in intestinal metaplasia of the stomach and relation of complete and incomplete types of metaplasia to minute gastric cancer. J Natl Cancer Inst. 1980;65:231–6.Google Scholar
  47. 47.
    Segura DI, Montera C. Histochemical characterisation of different types of intestinal metaplasia in the gastric mucosa. Cancer. 1983;52:498–503.PubMedCrossRefGoogle Scholar
  48. 48.
    Ma J, De Boer W, Nayman J. Intestinal mucinous substances in gastric intestinal metaplasia and carcinoma studied by immunofluorescence. Cancer. 1982;49:1664–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Slack J. From egg to embryo, 2nd edn. Cambridge: Cambridge University Press; 1993.Google Scholar
  50. 50.
    Soman NR, Correa P, Ruiz BA. The TYR-MET oncogenic rearrangement is present and expressed in human gastric and precursor lesions. Proc Natl Acad Sci USA. 1991;88:4892–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Taher E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993; 119:265–72.CrossRefGoogle Scholar
  52. 52.
    Hastie ND, Dempster M, Dunlop MG et al. Telomere reduction in human colorectal carcinoma and with aging. Nature. 1990;346:866–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Tahar E. Molecular biology of gastric cancer. World J Surg. 1995;19:484–90.CrossRefGoogle Scholar
  54. 54.
    Sipponen P, Kekki M, Seppala K et al. The relationship between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther. 1996;10(Suppl. 1): 103–18.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers and Axcan Pharma 1996

Authors and Affiliations

  • N. Wright

There are no affiliations available

Personalised recommendations